New cream could help men regrow hair – phase 3 trial complete
NCT ID NCT05914805
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tested a topical solution called clascoterone for male pattern hair loss. 762 men with mild to moderate balding applied the solution or a placebo twice daily for 6 months, followed by another 6 months for those who responded. The goal was to see if clascoterone could increase hair count and improve hair coverage. Results are not yet available, but if successful, this could become a new treatment option for hair loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- clascoterone solution (a topical cream applied to the scalp)
- What this could lead to
- If it works, this could provide a new topical treatment option for male pattern hair loss, helping to regrow hair and slow further loss.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. The treatment may not work better than placebo, and side effects like scalp irritation are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA, ANDROGENETIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Acclaim Dermatology LLC
Sugar Land, Texas, 77479, United States
-
Advanced Dermatology & Cosmetic Surgery
Spartanburg, South Carolina, 29307, United States
-
Austin Institute for Clinical Research
Pflugerville, Texas, 78660, United States
-
Carpe Diem Centrum Medycyny Estetycznej
Warsaw, 02-661, Poland
-
Centrum Medyczne All-med Badania Kliniczne
Krakow, 30-033, Poland
-
Centrum Medyczne Angelius Provita
Katowice, 40-611, Poland
-
Centrum Medyczne Pratia
Katowice, 40-081, Poland
-
Centrum Nowoczesnych Terapii Dobry Lekarz
Krakow, 31-011, Poland
-
Clinical Research Center for Hair and Skin Science, Dept. of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin
Berlin, 10117, Germany
-
DelRicht Research
Atlanta, Georgia, 30329, United States
-
DelRicht Research
Wildwood, Missouri, 63040, United States
-
DelRicht Research
Thompson's Station, Tennessee, 37179, United States
-
Department of Dermatology and Allergy, Johannes Gutenberg-Universität KöR
Mainz, 55131, Germany
-
Dermaticum-Privatpraxis für Dermatologie
Freiburg im Breisgau, 79098, Germany
-
Dermoklinika Centrum Medyczne s.c. M. Kierstan, J.Narbutt, A. Lesiak
Lodz, 90-436, Poland
-
Diamond Clinic Sp. z o.o.
Krakow, 31-559, Poland
-
Emovis GmbH
Berlin, 10629, Germany
-
Eurofins | bioskin
Hamburg, 20095, Germany
-
Grekin Skin Institute
Warren, Michigan, 48088, United States
-
Investigate MD
Scottsdale, Arizona, 85255, United States
-
Narodowy Instytut Geriatrii, Reumatologii iRehabilitacji im. prof. dr hab. med. Eleonory Reicher
Warsaw, 02-637, Poland
-
Physician's Institute of Cosmetic and Reconstructive Surgery
Hollywood, Florida, 33021, United States
-
Piedmont Plastic Surgery and Dermatology
Huntersville, North Carolina, 28078, United States
-
Premier Clinical Research
Spokane, Washington, 99202, United States
-
Privatpraxis Dr. Hilton & Partner
Düsseldorf, 40212, Germany
-
Pro Life Medica
Lublin, 20-412, Poland
-
Revival Research Institute
Troy, Michigan, 48084, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.